BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34397199)

  • 21. Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.
    Noels EC; Hollestein LM; van Egmond S; Lugtenberg M; van Nistelrooij LPJ; Bindels PJE; van der Lei J; Stern RS; Nijsten T; Wakkee M
    Br J Dermatol; 2019 Sep; 181(3):544-553. PubMed ID: 30636037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harmonisation of Outcome Parameters and Evaluation (HOPE) for actinic keratosis: protocol for the development of a core outcome set.
    Heppt MV; Steeb T; Schmitz L; Garbe C; French LE; Leiter U; Berking C
    Trials; 2019 Oct; 20(1):589. PubMed ID: 31604473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
    Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
    Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G;
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis.
    Stockfleth E; Peris K; Guillen C; Cerio R; Basset-Seguin N; Foley P; Sanches J; Culshaw A; Erntoft S; Lebwohl M
    Int J Dermatol; 2015; 54(5):509-15. PubMed ID: 25865875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy of actinic keratosis: an update.
    Berman B; Amini S
    Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.
    Werner RN; Stockfleth E; Connolly SM; Correia O; Erdmann R; Foley P; Gupta AK; Jacobs A; Kerl H; Lim HW; Martin G; Paquet M; Pariser DM; Rosumeck S; Röwert-Huber HJ; Sahota A; Sangueza OP; Shumack S; Sporbeck B; Swanson NA; Torezan L; Nast A; ;
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2069-79. PubMed ID: 26370093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes.
    Wood DLA; Lachner N; Tan JM; Tang S; Angel N; Laino A; Linedale R; Lê Cao KA; Morrison M; Frazer IH; Soyer HP; Hugenholtz P
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
    Lee AD; Jorizzo JL
    Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Italian expert consensus for the management of actinic keratosis in immunocompetent patients.
    Peris K; Calzavara-Pinton PG; Neri L; Girolomoni G; Malara G; Parodi A; Piaserico S; Rossi R; Pellacani G
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1077-84. PubMed ID: 27060910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [When and why treat actinic keratoses?].
    Wulf HC
    Ugeskr Laeger; 2014 Feb; 176(6A):V07130448. PubMed ID: 25347437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary management of actinic keratosis.
    Navarrete-Dechent C; Marghoob AA; Marchetti MA
    J Dermatolog Treat; 2021 Aug; 32(5):572-574. PubMed ID: 31621454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.
    Poulin Y; Lynde CW; Barber K; Vender R; Claveau J; Bourcier M; Ashkenas J;
    J Cutan Med Surg; 2015; 19(3):227-38. PubMed ID: 25926621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current role of in vivo reflectance confocal microscopy within the continuum of actinic keratosis and squamous cell carcinoma: a systematic review.
    Nguyen KP; Peppelman M; Hoogedoorn L; Van Erp PE; Gerritsen MP
    Eur J Dermatol; 2016 Dec; 26(6):549-565. PubMed ID: 28007674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-centered management of actinic keratosis. Results of a multi-center clinical consensus analyzing non-melanoma skin cancer patient profiles and field-treatment strategies.
    Philipp-Dormston WG; Battistella M; Boussemart L; Di Stefani A; Broganelli P; Thoms KM
    J Dermatolog Treat; 2020 Sep; 31(6):576-582. PubMed ID: 31625770
    [No Abstract]   [Full Text] [Related]  

  • 37. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
    Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM;
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
    JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma based on in vivo analysis of optical properties by high-definition optical coherence tomography.
    Boone MA; Suppa M; Marneffe A; Miyamoto M; Jemec GB; Del Marmol V
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):1714-1725. PubMed ID: 27311752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDT.
    Calzavara-Pinton P; Hædersdal M; Barber K; Basset-Seguin N; Del Pino Flores ME; Foley P; Galimberti G; Gerritsen R; Gilaberte Y; Ibbotson S; Peris K; Sapra S; Sotiriou E; Torezan L; Ulrich C; Guillemot J; Hendrich J; Szeimies RM
    J Cutan Med Surg; 2017; 21(1_suppl):3S-16S. PubMed ID: 28406719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.